Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14090927
Abstract: Pazopanib is a potent multi-targeted kinase inhibitor approved for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. The pharmacokinetics of pazopanib is characterized by a significant inter- and intra-patient variability and a… read more here.
Keywords: pazopanib; analysis pazopanib; population pharmacokinetic; target ... See more keywords